Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections,
LEXINGTON, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed.